NCT03509597

Brief Summary

This study evaluates the brain correlates of Cognitive Training and Aerobic Exercise in schizophrenia. A third of participants will receive Cognitive Training plus Standard Care for schizophrenia. Another third of participants will receive Aerobic Exercise Training plus Standard Care for schizophrenia. A control group will of participants will receive Standard Care plus Occupational Activities for the same duration and frequency as the experimental groups.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for not_applicable schizophrenia

Timeline
Completed

Started Mar 2017

Typical duration for not_applicable schizophrenia

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2017

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

April 11, 2018

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 26, 2018

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2019

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2020

Completed
Last Updated

July 30, 2019

Status Verified

July 1, 2019

Enrollment Period

2.8 years

First QC Date

April 11, 2018

Last Update Submit

July 26, 2019

Conditions

Keywords

Cognitive remediationAerobic exercisePhysical exerciseNegative symptomsFunctional outcomeCognition

Outcome Measures

Primary Outcomes (4)

  • Grey Matter Volume Change

    Assessment of Grey Matter volume changes (T1-weighted MRI) among the 3 groups using Voxel Based Morphometry (VBM).

    5 months

  • Fractional Anisotropy Change

    Assessment of changes in fractional anisotropy of White Matter fibers by Diffusion Tensor MR Imaging and using the Tract-Based Spatial Statistics (TBSS).

    5 months

  • Functional Magnetic Resonance Imaging (fMRI) Change at Rest

    Assessment of changes in fMRI at rest with the Coon Functional Connectivity Toolbox.

    5 months

  • Functional Magnetic Resonance Imaging (fMRI) Change during the performance of a cognitive paradigm.

    Assessment of changes in fMRI during the performance of a cognitive paradigm with Statistical Parametric Mapping (SPM8).

    5 months

Secondary Outcomes (37)

  • Serum BDNF

    5 months.

  • Clinical Symptoms of Schizophrenia measured by the Positive and Negative Symptoms Scale (PANSS).

    5 months.

  • Negative Symptoms of Schizophrenia measured by the Brief Negative Symptoms Scale (BNSS).

    5 months

  • Negative Symptoms of Schizophrenia measured by the Clinical Assessment Interview for Negative Symptoms Scale (CAINS)

    5 months

  • Functional Outcome measured by the UCSD Performance Based Assessment of Functional Skills in Severe Mental Illness (UPSA).

    5 months

  • +32 more secondary outcomes

Study Arms (3)

Aerobic Exercise

EXPERIMENTAL

This program consists of an exercise dosage of 180 min/week administered in 3 sessions of 60 minutes. Each session includes 10 minutes of warm-up exercise before the main exercise and 10 minutes of cool-down afterwards.the principal exercise section includes 20 minutes of aerobic exercise and 20 minutes of resistance and strength exercises. The exercise intensity will be regulated according to the heart rate measured by a pulsimeter throughout the exercise. The target intensity level will be individualized according to the heart rate to set the moderate intensity level (HR values between ventilatory thresholds) and high intensity level (HR values from 2nd. ventilatory threshold to the peak threshold).

Behavioral: Aerobic Exercise

Cognitive Training

EXPERIMENTAL

The CT group participates in a cognitive remediation program. This program consists of 3 sessions of 60 minutes per week. CT will be administered in groups of 5-8 subjects. The cognitive domains involved in the CT are attention/concentration, memory/learning, language, executive functions, social cognition, social skills, daily living activities and psychoeducation. Cognitive Remediation will be provided by using REHACOP, a cognitive remediation training tool designed and validated for Spanish patients with schizophrenia.

Behavioral: Cognitive Training

Treatment as usual

SHAM COMPARATOR

The TaU Group receives the usual treatment that patients with schizophrenia in Spain enriched with occupational activities administered 3 times a week with a duration of 60 minutes each session.

Behavioral: Treatment as usualBehavioral: Occupational Activities

Interventions

Physical exercise training consisting of aerobic exercise and strength/resistance training.

Aerobic Exercise

Cognitive remediation program using REHACOP rehabilitation program.

Cognitive Training

Standard care for schizophrenia + Leisure and free time activities.

Treatment as usual

Engagement in activities aimed to keep patients actively involved in demanding tasks.

Treatment as usual

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of Schizophrenia (DSM-5 F20.9)
  • More than 2 years since the onset of the disease.
  • Stable cognitive impairment.
  • Moderate severity of cognitive impairment in MATRICS scores (T score \< 40 in, at least, 1 out of 7 cognitive domains).

You may not qualify if:

  • Subjects clinically unstable (PANSS positive score \> 19).
  • Cognitive impairment due to another medical condition (neurocognitive disorders, brain injury, intellectual disability, etc.)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Psiquiatrico de Alava. Red Salud Mental de Araba

Vitoria-Gasteiz, Alava, 01006, Spain

RECRUITING

Related Publications (8)

  • Sanchez P, Pena J, Bengoetxea E, Ojeda N, Elizagarate E, Ezcurra J, Gutierrez M. Improvements in negative symptoms and functional outcome after a new generation cognitive remediation program: a randomized controlled trial. Schizophr Bull. 2014 May;40(3):707-15. doi: 10.1093/schbul/sbt057. Epub 2013 May 18.

  • Ojeda N, Pena J, Bengoetxea E, Garcia A, Sanchez P, Elizagarate E, Segarra R, Ezcurra J, Gutierrez-Fraile M, Eguiluz JI. [REHACOP: a cognitive rehabilitation programme in psychosis]. Rev Neurol. 2012 Mar 16;54(6):337-42. Spanish.

  • Pena J, Ibarretxe-Bilbao N, Sanchez P, Uriarte JJ, Elizagarate E, Gutierrez M, Ojeda N. Mechanisms of functional improvement through cognitive rehabilitation in schizophrenia. J Psychiatr Res. 2018 Jun;101:21-27. doi: 10.1016/j.jpsychires.2018.03.002. Epub 2018 Mar 6.

  • Pena J, Ibarretxe-Bilbao N, Sanchez P, Iriarte MB, Elizagarate E, Garay MA, Gutierrez M, Iribarren A, Ojeda N. Combining social cognitive treatment, cognitive remediation, and functional skills training in schizophrenia: a randomized controlled trial. NPJ Schizophr. 2016 Nov 9;2:16037. doi: 10.1038/npjschz.2016.37. eCollection 2016.

  • Ojeda N, Pena J, Bengoetxea E, Garcia A, Sanchez P, Elizagarate E, Segarra R, Ezcurra J, Gutierrez-Fraile M, Eguiluz JI. [Evidence of the effectiveness of cognitive rehabilitation in psychosis and schizophrenia with the REHACOP programme]. Rev Neurol. 2012 May 16;54(10):577-86. Spanish.

  • Ojeda N, Pena J, Sanchez P, Bengoetxea E, Elizagarate E, Ezcurra J, Gutierrez Fraile M. Efficiency of cognitive rehabilitation with REHACOP in chronic treatment resistant Hispanic patients. NeuroRehabilitation. 2012;30(1):65-74. doi: 10.3233/NRE-2011-0728.

  • Tous-Espelosin M, Pavon C, Elizagarate E, Sampedro A, Maldonado-Martin S. As We Were and As We Should Be, Combined Exercise Training in Adults With Schizophrenia: CORTEX-SP Study Part II. Scand J Med Sci Sports. 2024 Aug;34(8):e14707. doi: 10.1111/sms.14707.

  • Tous-Espelosin M, de Azua SR, Iriarte-Yoller N, MartinezAguirre-Betolaza A, Sanchez PM, Corres P, Arratibel-Imaz I, Sampedro A, Pena J, Maldonado-Martin S. Clinical, physical, physiological, and cardiovascular risk patterns of adults with schizophrenia: CORTEX-SP study: Characterization of adults with schizophrenia. Psychiatry Res. 2021 Jan;295:113580. doi: 10.1016/j.psychres.2020.113580. Epub 2020 Nov 18.

MeSH Terms

Conditions

SchizophreniaMotor Activity

Interventions

ExerciseCognitive TrainingTherapeutics

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental DisordersBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaNeurological RehabilitationRehabilitationAftercareContinuity of Patient CarePatient CareHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Pedro M Sanchez Gomez, MD

    Hospital Psiquiatrico de Alava. Red de Salud Mental de Araba.

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Pedro M Sanchez Gomez, MD

CONTACT

Edorta J Elizagarate Zabala, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Patients are trained to not comment about the type of treatment they have been assigned to with the investigator who performs the assessments.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized parallel assignment: Cognitive Training, Aerobic Exercise \& Treatment as usual.
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 11, 2018

First Posted

April 26, 2018

Study Start

March 1, 2017

Primary Completion

December 31, 2019

Study Completion

June 1, 2020

Last Updated

July 30, 2019

Record last verified: 2019-07

Locations